Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®

On April 8, 2021 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported that the company will present new data in scientific posters to be presented at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2021, which will be held online, April 10-15, 2021 and May 17-21, 2021 (Press release, Personalis, APR 8, 2021, View Source [SID1234577754]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

These abstracts showcase data from ImmunoID NeXT, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The ImmunoID NeXT Platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.

Following are details and links to the scientific posters that will be presented at the online meeting.

Poster Number, Session Category and Session Title

Title & Presenter

Date

Location

399

Clinical Research (Excluding Trials)

Biomarkers Predictive of Therapeutic Benefit

Pan-cancer survey of HLA loss of heterozygosity using a robustly validated NGS-based machine learning algorithm

Presenter: Rachel Marty Pyke, PhD

April 10, 2021

Online

555

Clinical Research (Excluding Trials)

Liquid Biopsies: Circulating DNA

Longitudinal exome-scale liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy

Presenter: Charles Abbott, PhD

April 10, 2021

Online

1898

Immunology
Tumor

Antigenicity/Processing and Presentation

Accurate modeling of antigen processing and MHC peptide presentation using large-scale immunopeptidomes and a novel machine learning framework

Presenter: Rachel Marty Pyke, PhD

April 10, 2021

Online

2227

Molecular and Cellular Biology / Genetics

Genomic Profiling of Tumors

Pan-cancer shedding patterns of tumor circulating cell free DNA

Presenter: Fábio Navarro, PhD

April 10, 2021

Online

2241

Molecular and Cellular Biology / Genetics

Genomic Profiling of Tumors

Profiling tumor-infiltrating immune cells using an augmented transcriptome

Presenter: Eric Levy, PhD

April 10